ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 204

Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis

Vanessa L. Kronzer1, Cynthia S. Crowson2, Jeffrey A. Sparks3, Robert Vassallo4 and John M. Davis III5, 1Internal Medicine, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN, 3Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 4Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Asthma and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Epidemiology and Public Health Poster I: Rheumatoid Arthritis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Several studies show an association between asthma and RA. However, none have controlled for allergic disease, urban environment, or passive smoke exposure. We aimed to determine the association of asthma, allergic disease, and passive smoke exposure with RA risk.

Methods: We performed a case-control study using a biobank at a single center, identifying cases of RA using a rules-based algorithm combining self-report with two diagnosis codes (PPV = 88%). We matched each case to three controls based on age, sex, and location of residence at index date of survey. Data on exposures were self-reported on biobank surveys. Unconditional logistic regression models calculated the relationship between each exposure and RA after adjusting for potential confounders.

Results: We identified 1,149 RA cases and 3,441 controls. Mean age at survey date was 62 years (SD 13), and 72% were female. Asthma was associated with RA even after adjusting for allergies, urban environment, and passive smoke exposure (Table 1). History of allergic disease was also associated with RA (Table 1). Passive home smoke exposure duration and pack-years were modestly associated with development of RA, but the association with passive work smoke exposure was not statistically significant (Table 1).

Conclusion: Asthma, allergic diseases, and passive smoke exposure at home may be associated with increased risk of developing RA. Future studies investigating the relationship between atopy and autoimmunity are needed.

Table 1. Association between asthma, allergy, passive smoke exposure and RA*

Number (%) or Median (IQR)

Characteristic

Controls (N = 3441)

RA cases (N = 1149)

Adjusted Odds Ratio* (95% CI)

Model N

Asthma

434 (13)

198 (18)

1.40 (1.16,1.69)

4492

Asthma after further adjustment**

434 (13)

198 (18)

1.31 (1.08,1.59)

3295

urban environment

2546 (75)

833 (73)

0.96 (0.82,1.12)

3295

allergic disease

1933 (57)

718 (63)

1.23 (1.06,1.43)

3295

Passive home smoke exposure

Yes

2095 (61)

753 (66)

1.1 (0.97,1.30)

4555

Age it began***

3 (3,15)

3 (3,15)

1.00 (0.99,1.01)

1966

Duration before RA, per 10 years

18 (10,20)

18 (10,21)

1.12 (1.01,1.23)

1795

Packs per day

0.8 (0.5,1.5)

0.8 (0.5,1.5)

1.1 (0.97,1.33)

1950

Pack-years before RA, per 10 years

12 (7,24)

14 (8,27)

1.06 (1.01,1.13)

1725

Passive work smoke exposure

Yes

1219 (36)

444 (39)

1.0 (0.90,1.21)

4552

Age it began***

25 (17,25)

25 (17,25)

1.01 (0.99,1.03)

1110

Duration before RA, per 10 years

10 (4,19)

10 (5,19)

0.99 (0.84,1.17)

1003

Packs per day

0.8 (0.5,1.5)

0.8 (0.5,1.5)

1.2 (0.99,1.36)

1102

Pack-years before RA, per 10 years

8 (3,15)

8 (4,17)

1.07 (0.99,1.16)

941

*adjusting for body mass index, race, education, personal smoking

**also adjusting for allergic disease, urban environment, and home/work smoke exposure

***also adjusting for the pack-years of passive smoke exposure


Disclosure: V. L. Kronzer, None; C. S. Crowson, None; J. A. Sparks, None; R. Vassallo, None; J. M. Davis III, None.

To cite this abstract in AMA style:

Kronzer VL, Crowson CS, Sparks JA, Vassallo R, Davis JM III. Investigating Asthma, Allergic Disease, Passive Smoke Exposure, and Risk of Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/investigating-asthma-allergic-disease-passive-smoke-exposure-and-risk-of-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-asthma-allergic-disease-passive-smoke-exposure-and-risk-of-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology